Austin, TXCIK 19402725 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
249 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Abivax SA | 1.32M | $177.65M | 13.3% | −33.5K | Reduced |
| 2 | Protagonist Therapeutics Inc | 1.05M | $91.63M | 6.9% | +60.0K | Added |
| 3 | Roivant Sciences Ltd | 3.43M | $74.41M | 5.6% | +81.5K | Added |
| 4 | Immunovant Inc |
| 2.48M |
| $63.07M |
| 4.7% |
| +239.2K |
| Added |
| 5 | Avidity Biosciences Inc | 546.5K | $39.42M | 2.9% | +492.9K | Added |
| 6 | Ea Series Trust | 337.1K | $38.80M | 2.9% | 0 | Held |
| 7 | Spdr S&P 500 ETF Tr | 54.7K | $37.29M | 2.8% | 0 | Held |
| 8 | Cytokinetics Inc | 540.2K | $34.32M | 2.6% | +21.2K | Added |
| 9 | Septerna Inc | 1.16M | $32.27M | 2.4% | −18.9K | Reduced |
| 10 | Arbutus Biopharma Corp | 5.42M | $26.05M | 1.9% | +2.51M | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio